Final report of the Lyme disease review panel of the Infectious Diseases Society of America.
In April 2008, the Infectious Diseases Society of America (IDSA) entered into an agreement with Connecticut Attorney General Richard Blumenthal to voluntarily undertake a special review of its 2006 Lyme disease guidelines. This agreement ended the Attorney General's investigation into the process by which the guidelines were developed. The IDSA agreed to convene an independent panel to conduct a one-time review of the guidelines. The Review Panel members, vetted by an ombudsman for potential conflicts of interest, reviewed the entirety of the 2006 guidelines, with particular attention to the recommendations devoted to post-Lyme disease syndromes. After multiple meetings, a public hearing, and extensive review of research and other information, the Review Panel concluded that the recommendations contained in the 2006 guidelines were medically and scientifically justified on the basis of all of the available evidence and that no changes to the guidelines were necessary.
Lantos
Paul M
PM
Duke University Medical Center, Durham, North Carolina 27710, USA. paul.lantos@duke.edu
Charini
William A
WA
Medoff
Gerald
G
Moro
Manuel H
MH
Mushatt
David M
DM
Parsonnet
Jeffrey
J
Sanders
John W
JW
Baker
Carol J
CJ
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016363:Antitrust Laws; D016265:Conflict of Interest; D003237:Connecticut; D004334:Drug Administration Schedule; D006291:Health Policy; D006801:Humans; D008193:Lyme Disease / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012955:Societies, Medical / Q000331:legislation & jurisprudence; D014481:United States
D000900:Anti-Bacterial Agents